Shares of Johnson & Johnson
JNJ,
sank 0.13% to $143.68 Wednesday, on what proved to be an all-around dismal buying and selling session for the stock market, with the S&P 500 Index
SPX,
falling 0.16% to three,629.65 and Dow Jones Industrial Common
DJIA,
falling 0.58% to 29,872.47. Johnson & Johnson closed $13.32 in need of its 52-week excessive ($157.00), which the corporate achieved on April 23rd.
The stock demonstrated a combined efficiency when in comparison with a few of its opponents Wednesday, as Roche Holding AG Half. Cert.
RHHVF,
remained unchanged, Merck & Co. Inc.
MRK,
fell 0.10% to $80.06, and Pfizer Inc.
PFE,
fell 0.19% to $36.53. Buying and selling quantity (7.6 M) eclipsed its 50-day common quantity of 6.eight M.
Editor’s Word: This story was auto-generated by Automated Insights utilizing information from Dow Jones and FactSet. See our market information phrases of use.
